ACHC

Acadia Healthcare Company, Inc. (ACHC) | Rumor.io

Acadia Healthcare

ACHC

Attention (50-day avg)0%

Attention rank (50-day avg)#2,632

Bullish sentiment (50-day avg)16%

Price to earnings ratio20.6

Market capitalization2.6B

Earnings per share-12.4

Dividend yield (TTM)—

Revenue (annual)3.3B

Net income (annual)-1.1B

Social

What share of all stock conversation is about ACHC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% 0

Aug 26

Buckley Capital's recent purchase of ACHC stock is based on its potential for $4/share in EPS in the next 3-4 years, which could make it a $48-$80 stock.
ACHC stock increased by approximately 6% on positive healthcare volume and steady buying, with the share price reaching $31.67.
ACHC's short-term trend has turned bullish, with indicators such as the MACD golden cross, rising RSI, and breakout above trendline supporting a continuation of the upward move.

Generated by AI

Sentiment

Of the messages about ACHC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	52.98% +15.85
Bearish	—	—	—	47.02% -15.85

Bullish· Feb 11

David Einhorn's investment in $ACHC is a bullish signal, citing the company's improving balance sheet and potential for a turnaround.
$ACHC's significant price increase, up 15.1%, is driven by short-term buying and short covering, as well as elevated option/flow activity.
The company's valuation is seen as disconnected from its subscriber base, presenting a potential opportunity for investors to buy in at a discount.

Bearish· Oct 25

Acadia Healthcare's shares have dropped significantly, with a 23% decline in a single day, following a disappointing earnings report and revenue miss.
The company's earnings miss has led to target price cuts from analysts, with Robert W. Baird reducing its target price from $55 to $38 and Deutsche Bank downgrading its recommendation from Buy to Hold.
Acadia Healthcare's stock has been downgraded by multiple analysts, with Robert W. Baird downgrading its recommendation from Outperform to Neutral, and Deutsche Bank downgrading its recommendation from Buy to Hold.

Generated by AI

Topics

Of the messages about ACHC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	0%	0%	16.67%	13.06%
Announcements	20%	20%	16.67%	33.27%
Analysts	80%	80%	66.67%	52.77%
Controversies	0%	0%	0%	0.18%
Earnings	0%	0%	0%	0.72%
Macro	0%	0%	0%	0%

Earnings· Nov 5

Acadia Healthcare's Q3 earnings missed estimates, with a reported EPS of 52c, missing the Estimize consensus by 2c.
Revenue for Q3 came in at $777.25M, missing the Estimize consensus by $6.53M.
The company's shares fell 7% after hours due to the Q3 miss and guidance cut.

Announcements· Sep 24

Engine Capital, a fund, has built a 3% stake in Acadia Healthcare and has written a letter to the company's board requesting a review of its asset portfolio, improvements to its board, and the halting of capital-intensive projects.
The board reshuffle initiated by Engine Capital has led to an increase in Acadia Healthcare's stock price, with some reports suggesting that the company may consider selling assets to unlock value for shareholders.
Acadia Healthcare's shares have been trading higher following the news, with some analysts suggesting that the company's massive upside potential could be unlocked by Engine Capital's stake and push for strategic changes.

Controversies· Sep 2

Acadia Healthcare has been accused of holding patients against their will to increase insurance payouts, violating the law in at least 12 states.
A New York Times investigation found that Acadia lured patients into its psychiatric hospitals and detained them even when it was not medically necessary.
Acadia employees reportedly used strategies such as exaggerating patients' symptoms and tweaking medication dosages to persuade insurers to cover longer stays.

Technical Analysis· Jan 20

A potential target price for Acadia Healthcare Company, Inc. is $17, which could be reevaluated if a breakout above this level occurs.
The post suggests that Acadia Healthcare Company, Inc. may be due for a higher target price after breaking above $17.
Technical analysis is being used to evaluate Acadia Healthcare Company, Inc. for potential future price movements.

Generated by AI

Community

Of the messages about ACHC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	71.43%	71.43%	92.11%	16.91%
Newcomers	28.57%	28.57%	7.89%	83.09%

Regulars· Dec 3

Acadia Healthcare's $ACHC stock price has dropped significantly due to reduced 2025 guidance, with analysts and investors expressing surprise over the flood of lawsuits and grand juries.
KeyBanc, UBS, Deutsche Bank, RBC, and Cantor Fitzgerald have all lowered their price targets for $ACHC, with Deutsche Bank analyst Pito Chickering making the largest price target movement by downgrading from $33 to $20.
BofA Securities has downgraded Acadia Healthcare to Underperform and slashed its price target to $13, citing higher insurance costs, litigation risks, and a persistent decline in future estimates.

Newcomers· Feb 11

The recent surge in Acadia Healthcare's stock price has been attributed to the involvement of David Einhorn, a prominent investor who has been buying the stock and is hopeful about the company's new management.
Newcomers to the stock are taking notice of the significant price increase, with some calling it a "pop" and others attributing it to a "reli harian terbaik kedua di 2026" (best second-day recovery in 2026).
The potential for Acadia Healthcare's stock to continue rising is being discussed, with one newcomer even going so far as to predict a price of $3, compared to the current price of $13.66.

Generated by AI

News

Acadia Healthcare Jumps 100% YTD on Improving Outlook and Expansion

ACHC shares have doubled YTD as a raised 2026 outlook, stronger cash flow and new facility openings bolster its rebound.

7d agoYahoo Finance

How Acadia Healthcare Is Turning Capacity Growth Into Cash Flow

ACHC is converting capacity expansion into stronger cash flow as new facilities mature, patient volumes rise and capital spending stays disciplined.

7d agoYahoo Finance

Acadia Healthcare Company (ACHC) Heads To Jefferies Conference, Is It Still A Bargain?

Acadia Healthcare Company (ACHC) is in focus after management booked a slot at the 2026 Jefferies Healthcare Services and Technology Conference in Nashville, drawing fresh attention to the behavioral health operator. Recent trading has been strong for Acadia Healthcare Company, with a 1-day share price return of 2.31% and a 90-day share price return of 15.84% at a latest share price of US$28.81. However, the 3-year total shareholder return has declined 59.12%, showing short term momentum...

12d agoYahoo Finance

Also Discussed

Investors talking about ACHC also mention

#	Name	Attention
1	Universal Health Services Inc. Class B Common StockUHS	0%0
2	Fortrea Holdings Inc.FTRE	0%0
3	Vestis CorporationVSTS	0%new
4	Dianthus Therapeutics Inc.DNTH	0%0
5	HCA Healthcare Inc.HCA	0%0
6	VanEck Consumer Discretionary TruSector ETFTRUD	0%0
7	Integra LifeSciences Holdings CorporationIART	0%0
8	Bruker CorpBRKR	0%0
9	Insight Enterprises, Inc.NSIT	0%0
10	Aurora Innovation, Inc. WarrantAUROW	0%-0.01

Acadia Healthcare Company, Inc.

Healthcare
Medical Care Facilities

Acadia Healthcare Company, Inc. is a behavioral healthcare services provider focused on delivering treatment across a range of clinical settings. The company operates acute inpatient psychiatric facilities, specialty treatment centers, residential treatment programs, comprehensive treatment centers, and outpatient behavioral health services. Its offerings address mental health conditions, substance use disorders, and related recovery needs for patients and communities. Acadia Healthcare serves individuals through a network designed to provide both short-term stabilization and longer-term therapeutic care, making it an important participant in the U.S. behavioral health market. The company’s business is centered on facility-based care, coordinated treatment pathways, and access to specialized services across multiple levels of acuity. Founded in 2005 and headquartered in Franklin, Tennessee, Acadia Healthcare Company, Inc. remains a significant operator in the healthcare services sector.

Website

Location

4020 Aspen Grove Drive

Franklin, TN, 37067

United States

Social

What share of all stock conversation is about ACHC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% 0

Aug 26

Buckley Capital's recent purchase of ACHC stock is based on its potential for $4/share in EPS in the next 3-4 years, which could make it a $48-$80 stock.
ACHC stock increased by approximately 6% on positive healthcare volume and steady buying, with the share price reaching $31.67.
ACHC's short-term trend has turned bullish, with indicators such as the MACD golden cross, rising RSI, and breakout above trendline supporting a continuation of the upward move.

Generated by AI

Sentiment

Of the messages about ACHC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	52.98% +15.85
Bearish	—	—	—	47.02% -15.85

Bullish· Feb 11

David Einhorn's investment in $ACHC is a bullish signal, citing the company's improving balance sheet and potential for a turnaround.
$ACHC's significant price increase, up 15.1%, is driven by short-term buying and short covering, as well as elevated option/flow activity.
The company's valuation is seen as disconnected from its subscriber base, presenting a potential opportunity for investors to buy in at a discount.

Bearish· Oct 25

Acadia Healthcare's shares have dropped significantly, with a 23% decline in a single day, following a disappointing earnings report and revenue miss.
The company's earnings miss has led to target price cuts from analysts, with Robert W. Baird reducing its target price from $55 to $38 and Deutsche Bank downgrading its recommendation from Buy to Hold.
Acadia Healthcare's stock has been downgraded by multiple analysts, with Robert W. Baird downgrading its recommendation from Outperform to Neutral, and Deutsche Bank downgrading its recommendation from Buy to Hold.

Generated by AI

Topics

Of the messages about ACHC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	0%	0%	16.67%	13.06%
Announcements	20%	20%	16.67%	33.27%
Analysts	80%	80%	66.67%	52.77%
Controversies	0%	0%	0%	0.18%
Earnings	0%	0%	0%	0.72%
Macro	0%	0%	0%	0%

Earnings· Nov 5

Acadia Healthcare's Q3 earnings missed estimates, with a reported EPS of 52c, missing the Estimize consensus by 2c.
Revenue for Q3 came in at $777.25M, missing the Estimize consensus by $6.53M.
The company's shares fell 7% after hours due to the Q3 miss and guidance cut.

Announcements· Sep 24

Engine Capital, a fund, has built a 3% stake in Acadia Healthcare and has written a letter to the company's board requesting a review of its asset portfolio, improvements to its board, and the halting of capital-intensive projects.
The board reshuffle initiated by Engine Capital has led to an increase in Acadia Healthcare's stock price, with some reports suggesting that the company may consider selling assets to unlock value for shareholders.
Acadia Healthcare's shares have been trading higher following the news, with some analysts suggesting that the company's massive upside potential could be unlocked by Engine Capital's stake and push for strategic changes.

Controversies· Sep 2

Acadia Healthcare has been accused of holding patients against their will to increase insurance payouts, violating the law in at least 12 states.
A New York Times investigation found that Acadia lured patients into its psychiatric hospitals and detained them even when it was not medically necessary.
Acadia employees reportedly used strategies such as exaggerating patients' symptoms and tweaking medication dosages to persuade insurers to cover longer stays.

Technical Analysis· Jan 20

A potential target price for Acadia Healthcare Company, Inc. is $17, which could be reevaluated if a breakout above this level occurs.
The post suggests that Acadia Healthcare Company, Inc. may be due for a higher target price after breaking above $17.
Technical analysis is being used to evaluate Acadia Healthcare Company, Inc. for potential future price movements.

Generated by AI

Community

Of the messages about ACHC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	71.43%	71.43%	92.11%	16.91%
Newcomers	28.57%	28.57%	7.89%	83.09%

Regulars· Dec 3

Acadia Healthcare's $ACHC stock price has dropped significantly due to reduced 2025 guidance, with analysts and investors expressing surprise over the flood of lawsuits and grand juries.
KeyBanc, UBS, Deutsche Bank, RBC, and Cantor Fitzgerald have all lowered their price targets for $ACHC, with Deutsche Bank analyst Pito Chickering making the largest price target movement by downgrading from $33 to $20.
BofA Securities has downgraded Acadia Healthcare to Underperform and slashed its price target to $13, citing higher insurance costs, litigation risks, and a persistent decline in future estimates.

Newcomers· Feb 11

The recent surge in Acadia Healthcare's stock price has been attributed to the involvement of David Einhorn, a prominent investor who has been buying the stock and is hopeful about the company's new management.
Newcomers to the stock are taking notice of the significant price increase, with some calling it a "pop" and others attributing it to a "reli harian terbaik kedua di 2026" (best second-day recovery in 2026).
The potential for Acadia Healthcare's stock to continue rising is being discussed, with one newcomer even going so far as to predict a price of $3, compared to the current price of $13.66.

Generated by AI

Acadia Healthcare

Social

Aug 26

Bullish· Feb 11

Bearish· Oct 25

Earnings· Nov 5

Announcements· Sep 24

Controversies· Sep 2

Technical Analysis· Jan 20

Regulars· Dec 3

Newcomers· Feb 11

Raymond James assumes Acadia Healthcare stock coverage with outperform rating

Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement

Hospital Chains Stocks Q2 Results: Benchmarking Acadia Healthcare (NASDAQ:ACHC)

Acadia Healthcare Jumps 100% YTD on Improving Outlook and Expansion

How Acadia Healthcare Is Turning Capacity Growth Into Cash Flow

Acadia Healthcare Company (ACHC) Heads To Jefferies Conference, Is It Still A Bargain?

Also Discussed

Acadia Healthcare Company, Inc.

Company Information

Location

Raymond James assumes Acadia Healthcare stock coverage with outperform rating

Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement

Hospital Chains Stocks Q2 Results: Benchmarking Acadia Healthcare (NASDAQ:ACHC)

Acadia Healthcare Jumps 100% YTD on Improving Outlook and Expansion

How Acadia Healthcare Is Turning Capacity Growth Into Cash Flow

Acadia Healthcare Company (ACHC) Heads To Jefferies Conference, Is It Still A Bargain?

Also Discussed

Social

Aug 26

Bullish· Feb 11

Bearish· Oct 25

Earnings· Nov 5

Announcements· Sep 24

Controversies· Sep 2

Technical Analysis· Jan 20

Regulars· Dec 3

Newcomers· Feb 11